XML 49 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
RESTATEMENT
3 Months Ended
Mar. 31, 2014
RESTATEMENT [Abstract]  
RESTATEMENT
15.RESTATEMENT

The consolidated financial statements as of March 31, 2014 and for the three-month period ended March 31, 2014 have been restated to correct the accounting related to (i) hyper-inflationary adjustments with respect to operations in Venezuela, and (ii) tax rebates related to the Company's new China headquarters. The hyper-inflationary currency translation adjustments should have been recorded as charges to Other Income (Expense) rather than as adjustments to Accumulated Other Comprehensive Loss.   The Company also should have recorded income to Other Income (Expense) for the China tax rebates.  The restatement makes these corrections by including a $21 million charge to Other Income (Expense) related to the hyper-inflationary accounting error and $7 million of income related to the China tax rebate. All other adjustments relate to the applicable income tax effects of these errors.  With respect to the hyper-inflationary correction, $15 million related to the first quarter of 2014, and $6 million related to periods prior to 2014.  With respect to the China tax rebates correction, $2 million related to the first quarter of 2014, and $5 million related to periods prior to 2014. The Company does not plan to amend financial statements for periods prior to 2014 as the amounts were determined to be immaterial. These changes, net of tax, negatively impacted net income for the three-month period ended March 31, 2014 by $9 million.
 
The following tables reconcile the amounts as originally reported in the Company's Original Form 10-Q for the quarter ended March 31, 2014 compared to the amounts as restated in this Form 10-Q/A.

NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
For the Three Month Period Ended March 31, 2014
(U.S. dollars in thousands, except per share amounts)


 
 
As Reported
  
As Restated
  
Difference
 
 
 
  
  
 
Revenue
 
$
671,061
  
$
671,061
  
$
-
 
 
            
Cost of sales
  
106,644
   
106,644
   
-
 
            
Gross profit
  
564,417
   
564,417
   
-
 
 
            
Operating expenses:
            
Selling expenses
  
313,101
   
313,101
   
-
 
General and administrative expenses
  
150,119
   
150,119
   
-
 
Total operating expenses
  
463,220
   
463,220
   
-
 
 
            
Operating income
  
101,197
   
101,197
   
-
 
 
            
Other income (expense), net
  
(3,604
)
  
(17,508
)
  
(13,904
)
Income before provision for income taxes
  
97,593
   
83,689
   
(13,904
)
Provision for income taxes
  
33,332
   
28,835
   
(4,497
)
            
Net income
 
$
64,261
  
$
54,854
  
$
(9,407
)
 
            
Net income per share:
            
Basic
 
$
1.09
  
$
0.93
  
$
(0.16
)
Diluted
 
$
1.05
  
$
0.90
  
$
(0.15
)
 
            
Weighted average common shares outstanding:
            
Basic
  
58,869
   
58,869
   
-
 
Diluted
  
61,227
   
61,227
   
-
 
 
 
NU SKIN ENTERPRISES, INC.
Consolidated Balance Sheets (Unaudited)
March 31, 2014
(U.S. dollars in thousands)

 
As Reported
 
As Restated
 
Difference
 
 
 
 
 
 
 
 
 
ASSETS
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
284,580
 
$
284,580
 
$
-
Current investments
 
18,703
 
 
18,703
 
 
-
Accounts receivable
 
56,644
 
 
56,644
 
 
-
Inventories, net
 
410,668
 
 
410,668
 
 
-
Prepaid expenses and other
 
149,523
 
 
150,375
 
 
852
 
920,118
 
 
920,970
 
 
852
 
 
 
 
 
 
 
 
 
Property and equipment, net
 
411,929
 
 
411,929
 
 
-
Goodwill
 
112,446
 
 
112,446
 
 
-
Other intangible assets, net
 
81,377
 
 
81,377
 
 
-
Other assets
 
115,751
 
 
115,751
 
 
-
Total assets
$
1,641,621
 
$
1,642,473
 
$
852
 
 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
Accounts payable
$
51,276
 
$
51,276
 
 
-
Accrued expenses
 
449,434
 
 
439,815
 
 
(9,619)
Current portion of debt
 
88,031
 
 
88,031
 
 
-
 
 
588,741
 
 
579,122
 
 
(9,619)
 
 
 
 
 
 
 
 
Long-term debt
 
109,882
 
 
109,882
 
 
-
Other liabilities
 
79,418
 
 
77,910
 
 
(1,508)
Total liabilities
 
778,041
 
 
766,914
 
 
(11,127)
 
 
 
 
 
 
 
 
 
Stockholders' equity:
 
 
 
 
 
 
 
 
Class A common stock
 
91
 
 
91
 
 
-
Additional paid-in capital
 
399,677
 
 
399,677
 
 
-
Treasury stock, at cost
 
(848,335)
 
 
(848,335)
 
 
-
Accumulated other comprehensive loss
 
(66,250)
 
 
(44,864)
 
 
21,386
Retained earnings
 
1,378,397
 
 
1,368,990
 
 
(9,407)
 
 
863,580
 
 
875,559
 
 
11,979
Total liabilities and stockholders' equity
$
1,641,621
 
$
1,642,473
 
$
852
 
 
NU SKIN ENTERPRISES, INC.
Consolidated Statements of Comprehensive Income (Unaudited)
For the Three Month Period Ended March 31, 2014
(U.S. dollars in thousands)


 
As Reported
 
As Restated
 
Difference
 
 
 
 
 
 
 
 
 
Net Income
$
64,261
 
$
54,854
 
$
(9,407)
 
 
 
 
 
 
 
 
 
Other comprehensive income, net of tax:
 
 
 
 
 
 
 
 
Foreign currency translation adjustment
 
(19,528)
 
 
1,858
 
 
21,386
Net unrealized gains on foreign currency cash flow hedges
 
(257)
 
 
(257)
 
 
-
Reclassification adjustment for realized losses (gains) in current earnings
 
(237)
 
 
(237)
 
 
-
 
 
(20,022)
 
 
1,364
 
 
21,386
 
 
 
 
 
 
 
 
 
Comprehensive income
$
44,239
 
$
56,218
 
$
11,979
 
 
 
NU SKIN ENTERPRISES, INC.
Consolidated Statements of Cash Flows (Unaudited)
For the Three Month Period Ended March 31, 2014
(U.S. dollars in thousands)


 
 
As Reported
  
As Restated
  
Difference
 
 
 
  
  
 
Cash flows from operating activities:
 
  
  
 
Net income
 
$
64,261
  
$
54,854
  
$
(9,407
)
Adjustments to reconcile net income to net cash provided by operating activities:
            
Depreciation and amortization
  
12,251
   
12,251
   
-
 
Foreign currency losses (gains)
  
3,445
   
24,831
   
21,386
 
Stock-based compensation
  
8,682
   
8,682
   
-
 
Deferred taxes
  
9,023
   
6,663
   
(2,360
)
Changes in operating assets and liabilities:
            
Accounts receivable
  
11,597
   
11,597
   
-
 
Inventories, net
  
(76,730
)
  
(76,730
)
  
-
 
Prepaid expenses and other
  
9,533
   
9,533
   
-
 
Other assets
  
(3,752
)
  
(3,752
)
  
-
 
Accounts payable
  
(30,692
)
  
(30,692
)
  
-
 
Accrued expenses
  
(166,830
)
  
(176,449
)
  
(9,619
)
Other liabilities
  
(1,388
)
  
(1,388
)
  
-
 
 
            
Net cash provided by (used in) operating activities
  
(160,600
)
  
(160,600
)
  
-
 
 
            
Cash flows from investing activities:
            
Purchases of property and equipment
  
(30,538
)
  
(30,538
)
  
-
 
Proceeds of investment sales
  
12,638
   
12,638
   
-
 
Purchases of investments
  
(9,556
)
  
(9,556
)
  
-
 
 
            
Net cash used in investing activities
  
(27,456
)
  
(27,456
)
  
-
 
 
            
Cash flows from financing activities:
            
Exercise of employee stock options
  
(8,375
)
  
(8,375
)
  
-
 
Payment of debt
  
(5,834
)
  
(5,834
)
  
-
 
Payment of cash dividends
  
(20,141
)
  
(20,141
)
  
-
 
Income tax benefit of options exercised
  
5,610
   
5,610
   
-
 
Proceeds from debt
  
20,000
   
20,000
   
-
 
Repurchases of shares of common stock
  
(25,002
)
  
(25,002
)
  
-
 
 
            
Net cash used in financing activities
  
(33,742
)
  
(33,742
)
  
-
 
 
            
Effect of exchange rate changes on cash
  
(18,775
)
  
(18,775
)
  
-
 
 
            
Net increase/(decrease) in cash and cash equivalents
  
(240,573
)
  
(240,573
)
  
-
 
 
            
Cash and cash equivalents, beginning of period
  
525,153
   
525,153
   
-
 
 
            
Cash and cash equivalents, end of period
 
$
284,580
  
$
284,580
  
$
-